Acronym |
Definition |
1932 | FDA form for veterinary adverse drug reaction, lack of effectiveness, product defect report--mandatory |
1932a | FDA form for veterinary adverse drug reaction, lack of effectiveness, product defect report--voluntary |
21 CFR Part 314 Subpart H | Subpart of Part 314 pertaining to accelerated approval of drugs |
2301 | FDA form for transmittal of periodic reports and promotional material for new animal drugs |
348 | FDA form for sponsored travel |
3500 | FDA form for voluntary reporting of adverse events |
3500A | FDA form for mandatory reporting of adverse events |
356V | FDA form for new animal drug appication |
3R | Recruitment, Relocation bonuses, and Retention allowances |
406B | Section of the FDA Modernization Act dealing with getting feedback from our stakeholders |
482 | FDA form for notice of inspection |
483 | FDA form used as a written notice of deficiencies found in inspections |
505(b)(2) | A new drug application that contains full reports of investigations of safety and effectiveness but |
510(k) | Food, Drug, and Cosmetic Act Section 501(k), Pre-Market Notification |
510(k) | Food, Drug, and Cosmetic Act Section 510(k), Pre-Market Notification |
A-V | Arterio-Venous |
A-VO2 | Arterio-Venous Oxygen |
A/L | Annual Leave |
A2LA | American Association for Laboratory Accreditation |
AAALAC | Association for the Assessment and Accreditation of Laboratory Animal Care International |
AAAP | American Association of Avian Pathologists |
AAAS | American Association for the Advancement of Science |
AABB | American Association of Blood Banks |
AABP | American Association of Bovine Practitioners |
AACR | American Association for Cancer Research |
© Abbreviations.com